000 01078 a2200301 4500
005 20250513001036.0
264 0 _c19830527
008 198305s 0 0 eng d
022 _a0340-7004
024 7 _a10.1007/BF00205383
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRoeslin, N
245 0 0 _aRegional immunotherapy in resectable squamous cell lung carcinoma. Analysis of a randomized study.
_h[electronic resource]
260 _bCancer immunology, immunotherapy : CII
_c1982
300 _a174-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aBCG Vaccine
_xtherapeutic use
650 0 4 _aCarcinoma, Squamous Cell
_xsurgery
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aLung Neoplasms
_xsurgery
700 1 _aLang, J M
700 1 _aMorand, G
700 1 _aWihlm, J M
700 1 _aWitz, J P
773 0 _tCancer immunology, immunotherapy : CII
_gvol. 13
_gno. 3
_gp. 174-5
856 4 0 _uhttps://doi.org/10.1007/BF00205383
_zAvailable from publisher's website
999 _c6925682
_d6925682